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Nissl Staining: Background
• This staining method stains for intracellular granules 
called Nissl bodies—rosette-like formations of polysomes 
that are scattered within the rows of the rough 
endoplasmic reticulum (Bryne, Academic Press 2014).
• Dispersion of the granule cell layer is an indicator of TLE 
(Figure 2, arrows).
• Granule cell layer dispersion is confirmed by visual 
inspection. 
• The dispersion is caused by the demyelination of neurons 
(sclerosis).
• If dispersion is not present in any KA-injected mice, then 
gliosis is confirmed with combined GFAP/DAPI staining.
• Sclerosis and gliosis—the death of glial cells—are both 
strong indicators of epilepsy.
Introduction: Temporal Lobe Epilepsy
• Epilepsy is a neurological disorder that is characterized 
by repeated seizures. It affects ~ 2.9 million Americans 
(Karasin B, Karasin M., AORN 2017).
• Temporal lobe epilepsy (TLE) is the most prominent form 
of partial epilepsy in adults (Herzog et al., Arch Neurol 
1986).
• Reproductive endocrine comorbidities appear in patients 
with TLE at significantly higher rates than in the general 
population. These comorbidities include polycystic ovary 
syndrome, hypothalamic amenorrhea, 
hyperandrogenism, irregular menstrual cycle, lower 
testosterone levels, hypogonadism, erectile dysfunction, 
and decreased semen motility (Herzog, Zeitschrift Für
Epileptologie 2015).
Nissl Staining: Procedure
1. The mouse is killed, and the brain is quickly extracted.
2. After collection of hypothalamic slices for recording, the remaining brain containing the hippocampus is fixed in 
paraformaldehyde.
3. Fixed brain tissue is sectioned into 40-micrometer thick slices and preserved in phosphate buffered saline (PBS).
4. Brain slices are selected from the well tray and placed onto positively charged slides. 
5. The slides are put into PBS, EtOH, and Cresyl violet to stain for Nissl bodies.
6. A coverslip is placed over the slices and secured with Permount.
7. Slices are analyzed under a microscope for sclerosis. 
Nissl Staining: Graph
Conclusions
• Post KA injections, mice do not always have acute 
seizures; however, most do display signs of acute 
seizures. 
• Nissl staining does not always allow one to determine 
whether a mouse has TLE. 
• Additional methods must be utilized to provide 
sufficient evidence that the KA injections were 
successful.
Acute Behavioral Seizure Screening
• Following KA injections, the mice are recorded in an 
observation chamber for 4-5 hours.
• The recordings are viewed at a later time and screened 
for acute seizures to verify the KA injection.
• Acute seizures are divided into stages:
- Stage 1-3: Not recorded 
- Stage 4: Repetitive head and jaw movement
- Stage 5: Repetitive movement of front paws 
(“clawing”) and thrashing of tail 
- Stage 6: Violent jumping and dashing around the 
cage 
• The times and stages of all seizures are recorded.
FIG 1: Stained dorsal 
hippocampus at 40x 
magnification. Dispersion is 
not present. 
FIG 2:Stained dorsal 
hippocampus at 40x 
magnification. Dispersion 
is present.
These are brain slices from a mouse after 
Nissl staining. The arrow points at the dorsal 
hippocampus. 
Background
• It is believed that gonadotropin-releasing hormone 
(GnRH) neurons in the hypothalamus play an 
important role in the development of 
the aforementioned comorbidities.
• The kainic acid (KA) mouse model is used to study 
epilepsy-associated changes in GnRH neurophysiology.
• Our lab recently observed that the activity of GnRH 
neurons is altered in KA-injected mice (Li et al., eNeuro
2018).
• The brain is extracted 2 months after injection. The 
hypothalamus is used for patch clamp experiments, and 
the hippocampus is fixed for later use.
• To ensure validity of the data, we must verify the success 
of all KA injections as indicated by the presence of 
sclerosis and/or gliosis in the hippocampus.
• Nissl (Cresyl violet) staining is used to visually verify the 
presence of sclerosis.
Questions
• Do all KA injections effectively trigger seizures and later 
development of hippocampal damage?
• How effective are the different methods of verification?
Methods
• Post-injection video recordings were used to identify 
all seizures identifiable by behavioral changes.
• Nissl staining was used to screen for sclerosis in 
preserved hippocampal sections.
EtOH, PBS, and Cresyl violet stain are the 3 main chemicals used.The sectioned brain slices are preserved in a well 
tray containing PBS.
Future Work
• GFAP/DAPI staining will be used to determine gliosis.
• Recording of seizure activity by electroencephalogram 
(EEG) will verify seizures and development of TLE. 
Percentage of slices that showed dispersion of 
neurons. 
Prevalence of seizure types 
observed during the video 
recordings
Proportion of mice that had 
seizures 
